Incidence of Invasive Cervical Cancer in a Cohort of HIV-Seropositive Women Before and After the Introduction of Highly Active Antiretroviral Therapy
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 26 (4) , 377-380
- https://doi.org/10.1097/00042560-200104010-00016
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- Cancer risk among men with, or at risk of, HIV infection in southern EuropeAIDS, 2000
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJAMA, 1999
- Natural history of HIV infection in the_era of combination antiretroviral therapyAIDS, 1999
- Temporal Changes in the Rate of Progression to Death Among Italians With Known Date of HIV Seroconversion: Estimates of the Population Effect of TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Risk of invasive cervical cancer among women with, or at risk for, HIV infectionInternational Journal of Cancer, 1999
- Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort studyBMJ, 1999
- Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapyAIDS, 1998
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Expanded European AIDS case definitionThe Lancet, 1993